Results 71 to 80 of about 4,616 (237)

Medication-related osteonecrosis (MRONJ) of the mandible and maxilla

BMJ Case Reports, 2020
In 2003, Marx reported the first case of osteonecrosis of the jaw in 36 cases related to zoledronic acid or pamidronate. Painful bone exposure in the mandible or maxilla unresponsive to medical or surgical management was observed. In 2014, the American Association of Oral and Maxillofacial Surgeons proposed the term ‘medication-related osteonecrosis of
Dunphy L., Salzano G., Gerber B., Graystone J.   +3 more
openaire   +4 more sources

Will L‐PRF Be the Future of Endodontic Microsurgery? A Series of Case Reports

Clinical and Experimental Dental Research, Volume 11, Issue 6, December 2025.
ABSTRACT Objectives This case series aimed to evaluate the healing potential of apical tissues with large periapical radiolucencies (> 10 mm) after apical microsurgery with L‐PRF. The secondary objectives were to evaluate L‐PRF's benefits and adverse effects as well as to aid in the development of a clinical protocol.
Natrah Ahmad Fuad, Panagiotis Pitros, Graeme Brown, Eleni Besi   +3 more
wiley   +1 more source

The Use of Photodynamic Therapy on Medication-Related Osteonecrosis of the Jaws: Animal Study

Balkan Journal of Dental Medicine, 2021
Background/Aim: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) was first introduced in 2003 and its scope was expanded by the name medication-related osteonecrosis of the jaw (MRONJ), since 2014.
Karapinar Gökay, Zincir Özge Özdal, Ünür Meral, Olgaç Necat Vakur   +3 more
doaj   +1 more source

Prevalence and Risk Factors of Post‐Extraction Complications in a Western Australian Tertiary Dental Hospital: A Retrospective Cross‐Sectional Study

Australian Dental Journal, Volume 70, Issue 4, Page 266-274, December 2025.
ABSTRACT Objectives Dental extractions are routine procedures, yet they carry a risk of post‐operative complications that can negatively affect patients' quality of life. This study aimed to identify patient‐, tooth‐ and clinician‐related risk factors associated with post‐extraction complications at Western Australia's only tertiary dental hospital, to
Peter Dignam, Mariam Elshafey, Aparna Jeganathan, Magdalen Foo, Joon Soo Park, Manorika Ratnaweera   +5 more
wiley   +1 more source

Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?

PLoS ONE, 2018
Methods for preventing medication-related osteonecrosis of the jaw (MRONJ) in cancer patients who have received high-dose bisphosphonate (BP) or denosumab (Dmab) have not yet been established.
Sakiko Soutome, Saki Hayashida, Madoka Funahara, Yuki Sakamoto, Yuka Kojima, Souichi Yanamoto, Masahiro Umeda   +6 more
doaj   +1 more source

Effects of Type 2 Diabetes Mellitus on Osteoclast Differentiation, Activity, and Cortical Bone Formation in POSTmenopausal MRONJ Patients [PDF]

, 2022
Sung-Min Park, Jae‐Hoon Lee
openalex   +1 more source

Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis

Journal of Translational Medicine, 2019
Background With an increasing indication spectrum of antiresorptive drugs, the medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy [MRONJ (BP)] is continuously gaining clinical relevance.
Falk Wehrhan, Christian Gross, Kay Creutzburg, Kerstin Amann, Jutta Ries, Marco Kesting, Carol-Immanuel Geppert, Manuel Weber   +7 more
doaj   +1 more source

The use of advanced‐platelet rich fibrin (A‐PRF) in the management of medication‐related osteonecrosis of the jaw (MRONJ): A case report [PDF]

, 2023
M Asfour, Abeer A. Aljoujou, Maher Saifo, Haya A. L. Jabban   +3 more
openalex   +1 more source

Advances in Magnesium Metal and Its Alloys for Promoting Angiogenesis

Journal of Biomedical Materials Research Part B: Applied Biomaterials, Volume 113, Issue 11, November 2025.
ABSTRACT Magnesium‐based materials show great promise for bone repair due to their biodegradability, bone‐like mechanical properties, and dual pro‐angiogenic/osteogenic activities. Pure magnesium implants enhance vascularization in bone defect models through Mg2+ release.
Junjie Huang, Jialong Wu, Di Liu, Peng Gao   +3 more
wiley   +1 more source

Reduction of MRONJ risk after exodontia by virtue of ozone infiltration: A randomized clinical trial

Oral Diseases
Introduction Exodontia is commonly considered as a risk factor for the development of medication‐related osteonecrosis of the jaw (MRONJ) in individuals exposed to bone modifying agents.
O. Di Fede, Gaetano La Mantia, Carmine Del Gaizo, R. Mauceri, D. Matranga, G. Campisi   +5 more
semanticscholar   +1 more source